These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 26073366

  • 1. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC.
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 8. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors.
    Santagostino E, Escobar M, Ozelo M, Solimeno L, Arkhammar P, Lee HY, Rosu G, Giangrande P.
    Blood Rev; 2015 Jun; 29 Suppl 1():S9-18. PubMed ID: 26073369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New insights into the management of bleeding disorders.
    Escolar G.
    Drug News Perspect; 2004 May; 17(4):285-8. PubMed ID: 15334177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.